ENDRA Life Sciences Inc. (NDRA) Q1 2026 Annual Earnings
NDRA·Reported May 18, 2026·Before market open
Diluted EPS came in at $-1.09 (+57.9% YoY), beat the $-1.23 consensus by $0.14.
Diluted EPS
$-1.09beat by $0.14
Consensus: $-1.23
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about ENDRA Life Sciences Inc.'s Q1 2026 earnings report.
ENDRA Life Sciences Inc. (NDRA) reported Q1 2026 earnings on May 18, 2026 before market open.
ENDRA Life Sciences Inc. reported diluted EPS of $-1.09 for Q1 2026.
EPS beat the consensus estimate of $-1.23 by $0.14.
Compared to the same quarter a year prior, diluted EPS grew 57.9% from $-2.59.
You can read the 10-K periodic report (0001213900-26-037617) directly on SEC EDGAR. The filing index links above go to sec.gov.